[Exquisite sensitivity of TP53 mutant breast cancers to dose-dense chemotherapy].
Lehmann-Che
Jacqueline
J
Service de Biochimie et CNRS/ Université Paris VII UMR7151, Paris, France. jacqueline.lehmann-che@sls.aphp.fr
Turpin
Elisabeth
E
Bertheau
Philippe
P
Espié
Marc
M
de Thé
Hugues
H
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D005260:Female; D006801:Humans; D016019:Survival Analysis; D017741:Survivors; D016896:Treatment Outcome; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
D000970:Antineoplastic Agents; D016159:Tumor Suppressor Protein p53